-
Article | 2017.01.04
Pasteur-Cnam-EHESP School of Public Health
The Institut Pasteur and the Cnam (National Conservatory of Arts and Crafts), in partnership with the EHESP (French School of Public Health), have combined their complementary expertise within the Pasteur-Cnam-EHESP School of Public Health to offer an Advanced Master degree - Mastère Spécialisé in Public Health.
-
Document de presse | 2017.12.14
Sanofi and the Institut Pasteur reward five researchers for their major contributions in the service of human health
Paris, France – December 13th 2017 - Sanofi and the Institut Pasteur presented the Sanofi - Institut Pasteur Awards for the sixth year in a row.Five internationally recognized researchers were rewarded for their work in two major fields with implications for global health: Immunology and Microbiology & Infection. The National Junior award winnersDocteur Fabrizia Stavru – Bacteria-Cell...
-
News | 2017.12.18
Five young researchers from the Institut Pasteur International Network attended the 2017 PhD students' ceremony
Like every year since 2013, the Institut Pasteur organized on December 11th a ceremony in honor of the young graduates who defended their PhD thesis during the 2016-2017 academic year. The 2017 edition honored 34 young Pasteurian scientists, 5 of whom completed their thesis in an institution member of the Institut Pasteur International Network."We are pleased and proud to welcome these young...
-
News | 2018.06.05
An update on Ebola in the Democratic Republic of the Congo with Arnaud Fontanet, an expert at the Institut Pasteur
For several weeks, the Democratic Republic of the Congo has been facing a new outbreak of the hemorrhagic fever Ebola. Where does this virus come from? What is the latest on the current crisis? An update with Arnaud Fontanet, Professor at the CNAM and Head of the Epidemiology of Emerging Diseases Unit at the Institut Pasteur in Paris. Arnaud Fontanet, Professor at the CNAM and Head of...
-
News | 2022.11.14
Monkeypox: a detailed profile of the disease
Physicians and scientists from the Institut Pasteur, the Pasteur Network and ANRS | Emerging Infectious Diseases have conducted a review of the medical and scientific literature about monkeypox. The review, which paints a complete picture of the disease, was published in the New England Journal of Medicine on October 26, 2022. What are the signs of this disease? Where does it come from? How is it...
-
Document de presse | 2023.09.28
Malaria: treatment of Plasmodium falciparum malaria patients under threat in the Horn of Africa
Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health Organization (WHO), are under threat in the Horn of Africa. Scientists from the Laboratory of Parasitology and Medical Mycology at the University of Strasbourg and Strasbourg University Hospital, in...
-
Document de presse | 2013.05.05
Chikungunya : discovery of a human-specific factor involved in the virus replication
Scientists from the Institut Pasteur, Inserm and CNRS, have identified a human-specific factor involved in the replication of Chikungunya virus which accounts for the species specificity of this virus. Chikungunya virus is an emerging virus that in 2005 caused, for the first time, an outbreak in La Réunion island, a French overseas district where more than 30% of the population was infected, and...
-
Document de presse | 2011.03.31
AREVA Foundation and Institut Pasteur sign a new partnership agreement for Aids research
AREVA Foundation continues to fight Aids alongside the Institut Pasteur in 2011. Two new Institute teams will benefit from the continuing partnership: • the team led by Professor Olivier Schwartz, who directs the Virus and Immunity Research Unit • the team of Dr. Michaela Müller of the Retroviral Infection Regulation Unit directed by Professor Barré-Sinoussi, Nobel Prize in Medicine....
-
Document de presse | 2011.01.02
Hepatitis C : in 2011, a predictive marker for response to therapy
Scientists at Inserm and Institut Pasteur have performed biomarker discovery on patients being treated for chronic hepatitis C infection. Their work, published in The Journal of Clinical Investigation, demonstrates that the plasma levels of the protein IP-10 predict, prior to treatment initiation, the efficacy of treatment with pegylated-interferon and ribavirin. Based on these results, the...
-
Document de presse | 2013.08.01
Dengue: identifying mosquito genetic factors that control virus transmission
Dengue is currently the most common insect-borne viral disease of humans worldwide. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the Armed Forces Research Institute of Medical Sciences (AFRIMS) have discovered several genetic factors controlling the transmission of various dengue virus strains in a natural population of mosquitoes in...